Q10 PLUS 90 CAPS

Q10 Plus is a formula that has been specially developed to improve strength and muscle tone. Q10 Plus contains no co-enzyme Q10, taurine, Crataegus oxyacantha (the most important plant), magnesium, Ginkgo biloba and Lmethionine. Hartweefsel contains high concentrations of taurine. The bessen and bloesems of tweestijlige meidoorn are used for centuries to help prevent heart disease. Crateagus oxycantha is hardy for the weather, is good for the bloomsomloop and brings normal blooms to a standstill. Magnesium is essential for maintaining cardiovascular health. Ginkgo biloba optimises both periferal and arterial door blocking. L-methionine is a lipotropic amino acid.

1 capsule per day or as needed

1. Degenring FH, Suter A, Weber M, Saller R A randomised double blind placebo controlled clinical trial of a standardised extract of fresh
   Crataegus berries (Crataegisan) in the treatment of patients with congestive
   heart failure NYHA II.Phytomedicine. 2003;10(5):363-9.

2. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J Possible Cause
   of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action. J
   Cardiovasc Pharmacol. 2003 May;41(5):751-9

3. Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T,
   Schaffer SW, Azuma J. Taurine renders the cell resistant to ischemia-induced
   injury in cultured neonatal rat cardiomyocytes.J Cardiovasc Pharmacol. 2003
   May;41(5):726-33.

4. Sarter B Coenzyme Q10 and cardiovascular disease: a review. J
   Cardiovasc Nurs. 2002 Jul;16(4):9-20. Review.

5. Atar D., Mortensen S.A., Flachs H., Herzog W.R. Coenzyme Q10 Protects
   Ischemic Myocardium in an Open-Chest Swine Model. Clin. Investig, 1993, 71
   :S103-S111.

6. Baggio E., Gandini R., Plancher C., Passeri N., Carmosino G. Italian
   Multi-Centre Study on the Safety and Efficacy of Coenzyme Q10 as Adjuvant
   Therapy in Heart Failure. Clin. Investig, 1993, 71 :S145-S149.

7. di Palma A., Masini M., Cimatti G., Adamanti S., et al. Coenzyme Q10
   : a probable longevity marker. Biomed. And Clin. Aspects of Q10, 6 :489-
   492, 1991.

8. Hanaki Y., Sugiyama S., Ozawa T., Ohno M. Coenzyme Q10 and Coronary
   Artery Disease. Clin. Investig, 1993, 71 :S112- S115.

9. Judy W.V., Stogsdill W.W., Folkers K. Myocardial Preservation by
   Therapy With Coenzyme Q10 During Heart Surgery. Clin. Investig, 1993, 71
   :S155-S161.

10. Kamei M., Fujita T., Kanbe T., Saski K., et al. The distribution and
    content of ubiquinone in foods. Int. J. Vitam. Nutr. Res. 56 :1 :57-63,

12. Kuklinski B., von Appen S., Weissenbacher E. Coenzyme Q10 and
    Antioxidants in Acute Myocardial Infarction. 8th Int. Symp. Biomed. and
    Cln. Aspects of CoQ10, 1993, s. 32.

13. Mordente A., Martorana G.E., Santini S.A., Miggiano G.A.D.
    Antioxidant Effect of Coenzyme Q10 on Hydrogen Peroxide-activated Myoglobin.
    Clin. Investig, 1993, 71 :S92-S96.

14. Morisco C., Trimarco B., Condorelli M. Effect of Coenzyme Q10 Therapy
    in Patients with Congestive Heart Failure: A Long Term Multi-Centre
    Randomized Study. Clin. Investig, 1993, 71 :S134- S136.

15. Mortensen S.A., Vadhanavikit S., Muratsu K., Folkers K. CoQ10:
    Clinical benefits with biochem. Correlates suggesting a break through in the
    management of chronic heart failure. Int. J. Tiss. Reac. : 12 :3 :155-162,

17. Sugimoto M., Ideta T., Imanishi K., Ono T., et al. Effect of CoQ10 in
    patients with progressive muscular dystrophy and other neuromuscular
    diseases. Biomed. and Clin. Aspects of CoQ10. 1 :243-250, 1984.

18. Wilkinson E.G., Arnold R.M., Folkers K. Treatment of periodontal and
    other soft tissue diseases of the oral cavity with coenzyme Q. Biomed. and
    Clin. Aspects of CoQ10, 1 :251 :266, 1977.

19. Yamagami T., Takagi M., Akagami H., Folkers K. Effect on Q10 on
    essential hypertension, a double blind controlled study. Biomed. and Clin.
    Aspects of CoQ10. 5 :337-344, 1986.

20. Zeppilli P., Merlino B., de Luca A., Littaru G.P., et al. Influence
    of CoQ10 on physical work capacity of athletes, sedentary people and patients
    with mitochondrial disease. Biomed. and Clin. Aspects of Q10.

Niet te gebruiken bij: geen gevallen gekend.

INGREDIENTEN PER CAPSULE
Taurine	300 mg
Tweestijlige meidoorn (Crataegus oxyacantha)	100 mg
Magnesiumcitraat	80 mg
Kaliumcitraat	30 mg Ginkgo
Ginkgo biloba-extract (24% conc.)	20 mg
Co-enzym Q10 (ubiquinon)	10 mg
L-methionine	250 µg
Hulpstoffen: gelatine, microkristallijne cellulose, magnesiumstearaat *%RI = Referentie Inname (E.C.)